Roche Holding AG (RHHBF)
USD 303.32
(0.0%)
USD 303.32
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 7.74 Billion CHF | -9.95% |
| 2022 | 8.6 Billion CHF | 11.54% |
| 2021 | 7.71 Billion CHF | 7.24% |
| 2020 | 7.19 Billion CHF | 18.81% |
| 2019 | 6.05 Billion CHF | -8.55% |
| 2018 | 6.62 Billion CHF | -10.61% |
| 2017 | 7.4 Billion CHF | -6.57% |
| 2016 | 7.92 Billion CHF | 3.66% |
| 2015 | 7.64 Billion CHF | -1.23% |
| 2014 | 7.74 Billion CHF | 31.1% |
| 2013 | 5.9 Billion CHF | 6.57% |
| 2012 | 5.54 Billion CHF | 9.53% |
| 2011 | 5.06 Billion CHF | 1.77% |
| 2010 | 4.97 Billion CHF | -11.97% |
| 2009 | 5.64 Billion CHF | -3.12% |
| 2008 | 5.83 Billion CHF | -4.63% |
| 2007 | 6.11 Billion CHF | 9.32% |
| 2006 | 5.59 Billion CHF | 10.93% |
| 2005 | 5.04 Billion CHF | 10.21% |
| 2004 | 4.57 Billion CHF | -8.98% |
| 2003 | 5.02 Billion CHF | -12.21% |
| 2002 | 5.72 Billion CHF | -0.97% |
| 2001 | 5.78 Billion CHF | 0.45% |
| 2000 | 5.75 Billion CHF | -12.1% |
| 1999 | 6.54 Billion CHF | 21.47% |
| 1998 | 5.38 Billion CHF | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 7.94 Billion CHF | 0.0% |
| 2024 Q1 | 7.94 Billion CHF | 2.53% |
| 2023 Q2 | 8.49 Billion CHF | 0.0% |
| 2023 FY | 7.74 Billion CHF | -9.95% |
| 2023 Q3 | 7.74 Billion CHF | -8.79% |
| 2023 Q4 | 7.74 Billion CHF | 0.0% |
| 2023 Q1 | 8.49 Billion CHF | -1.27% |
| 2022 Q4 | 8.6 Billion CHF | 0.0% |
| 2022 FY | 8.6 Billion CHF | 11.54% |
| 2022 Q1 | 8.29 Billion CHF | 7.48% |
| 2022 Q2 | 8.29 Billion CHF | 0.0% |
| 2022 Q3 | 8.6 Billion CHF | 3.77% |
| 2021 Q4 | 7.71 Billion CHF | 0.0% |
| 2021 Q3 | 7.71 Billion CHF | -7.26% |
| 2021 Q2 | 8.31 Billion CHF | 0.0% |
| 2021 Q1 | 8.31 Billion CHF | 15.64% |
| 2021 FY | 7.71 Billion CHF | 7.24% |
| 2020 Q1 | 6.78 Billion CHF | 12.09% |
| 2020 FY | 7.19 Billion CHF | 18.81% |
| 2020 Q3 | 7.19 Billion CHF | 6.0% |
| 2020 Q4 | 7.19 Billion CHF | 0.0% |
| 2020 Q2 | 6.78 Billion CHF | 0.0% |
| 2019 Q3 | 6.05 Billion CHF | -7.89% |
| 2019 Q4 | 6.05 Billion CHF | 0.0% |
| 2019 FY | 6.05 Billion CHF | -8.55% |
| 2019 Q2 | 6.57 Billion CHF | 0.0% |
| 2019 Q1 | 6.57 Billion CHF | -0.71% |
| 2018 Q1 | 7.31 Billion CHF | -1.2% |
| 2018 Q3 | 6.62 Billion CHF | -9.52% |
| 2018 FY | 6.62 Billion CHF | -10.61% |
| 2018 Q2 | 7.31 Billion CHF | 0.0% |
| 2018 Q4 | 6.62 Billion CHF | 0.0% |
| 2017 Q4 | 7.4 Billion CHF | 0.0% |
| 2017 FY | 7.4 Billion CHF | -6.57% |
| 2017 Q3 | 7.4 Billion CHF | -4.02% |
| 2017 Q2 | 7.71 Billion CHF | 0.0% |
| 2017 Q1 | 7.71 Billion CHF | -2.66% |
| 2016 Q2 | 8.22 Billion CHF | 0.0% |
| 2016 Q1 | 8.22 Billion CHF | 7.49% |
| 2016 Q3 | 7.92 Billion CHF | -3.56% |
| 2016 Q4 | 7.92 Billion CHF | 0.0% |
| 2016 FY | 7.92 Billion CHF | 3.66% |
| 2015 FY | 7.64 Billion CHF | -1.23% |
| 2015 Q2 | 7.36 Billion CHF | 0.0% |
| 2015 Q4 | 7.64 Billion CHF | 0.0% |
| 2015 Q3 | 7.64 Billion CHF | 3.87% |
| 2015 Q1 | 7.36 Billion CHF | -4.91% |
| 2014 Q1 | 6.45 Billion CHF | 9.31% |
| 2014 Q3 | 7.74 Billion CHF | 19.93% |
| 2014 Q2 | 6.45 Billion CHF | 0.0% |
| 2014 FY | 7.74 Billion CHF | 31.1% |
| 2014 Q4 | 7.74 Billion CHF | 0.0% |
| 2013 FY | 5.9 Billion CHF | 6.57% |
| 2013 Q2 | 5.87 Billion CHF | 0.0% |
| 2013 Q4 | 5.9 Billion CHF | 0.0% |
| 2013 Q3 | 5.9 Billion CHF | 0.49% |
| 2013 Q1 | 5.87 Billion CHF | 6.04% |
| 2012 Q4 | 5.54 Billion CHF | 0.0% |
| 2012 Q2 | 5.51 Billion CHF | 0.0% |
| 2012 FY | 5.54 Billion CHF | 9.53% |
| 2011 Q2 | 4.65 Billion CHF | 0.0% |
| 2011 FY | 5.06 Billion CHF | 1.77% |
| 2011 Q4 | 5.06 Billion CHF | 0.0% |
| 2010 FY | 4.97 Billion CHF | -11.97% |
| 2010 Q2 | 5.59 Billion CHF | 0.0% |
| 2010 Q4 | 4.97 Billion CHF | 0.0% |
| 2009 Q4 | 5.64 Billion CHF | 0.0% |
| 2009 Q2 | 5.92 Billion CHF | 0.0% |
| 2009 FY | 5.64 Billion CHF | -3.12% |
| 2008 Q2 | 5.9 Billion CHF | 0.0% |
| 2008 FY | 5.83 Billion CHF | -4.63% |
| 2008 Q4 | 5.83 Billion CHF | 0.0% |
| 2007 Q2 | 6.27 Billion CHF | 0.0% |
| 2007 FY | 6.11 Billion CHF | 9.32% |
| 2007 Q4 | 6.11 Billion CHF | 0.0% |
| 2006 Q4 | 5.59 Billion CHF | 0.0% |
| 2006 FY | 5.59 Billion CHF | 10.93% |
| 2005 FY | 5.04 Billion CHF | 10.21% |
| 2004 FY | 4.57 Billion CHF | -8.98% |
| 2003 FY | 5.02 Billion CHF | -12.21% |
| 2002 FY | 5.72 Billion CHF | -0.97% |
| 2001 FY | 5.78 Billion CHF | 0.45% |
| 2000 FY | 5.75 Billion CHF | -12.1% |
| 1999 FY | 6.54 Billion CHF | 21.47% |
| 1998 FY | 5.38 Billion CHF | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AstraZeneca PLC | 5.41 Billion USD | -43.067% |
| Bristol-Myers Squibb Company PFD CONV 2 | 2.66 Billion USD | -191.097% |
| CSPC Pharmaceutical Group Limited | 442.43 Million USD | -1651.458% |
| Clarus Therapeutics Holdings, Inc. | 14.21 Million USD | -54416.674% |
| Novartis AG | 5.91 Billion USD | -31.05% |
| PT Kalbe Farma Tbk. | 451.27 Million USD | -1617.116% |